NYSE · Healthcare
UL Solutions Inc. (ULS)
As-reported financials and recent SEC filings for UL Solutions Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$3.05B
Net income
$325.0M
Net margin
10.6%
Diluted EPS
$1.60
ROE
25.1%
P/E (TTM)
57.6×
Market cap
$19.96B
Debt / equity
0.4×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2024 | FY2024 |
|---|---|---|---|---|
| Revenue | $3.05B | $2.87B | $2.68B | $2.52B |
| Gross profit | $1.51B | $1.39B | $1.28B | $1.21B |
| Operating income | $522.0M | $462.0M | $368.0M | $412.0M |
| Net income | $325.0M | $326.0M | $260.0M | $293.0M |
| Diluted EPS | $1.60 | $1.62 | $1.30 | $1.47 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-10
View on EDGAR →42026-06-10
View on EDGAR →42026-06-10
View on EDGAR →42026-06-10
View on EDGAR →42026-06-10
View on EDGAR →42026-06-10
View on EDGAR →42026-06-10
View on EDGAR →42026-06-10
View on EDGAR →Go deeper on ULS
Search UL Solutions Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.